Back to top
more

Applied Therapeutics (APLT)

(Real Time Quote from BATS)

$0.46 USD

0.46
294,023

+0.02 (4.38%)

Updated Aug 4, 2025 03:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (143 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Applied Therapeutics Inc. (APLT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Applied Therapeutics Inc. (APLT) closed the most recent trading day at $25.74, moving +1.74% from the previous trading session.

Zacks Equity Research

What to Expect for Applied Therapeutics (APLT) Q2 Earnings

by Zacks Equity Research

During Applied Therapeutics' (APLT) upcoming Q2 earnings call, investor focus will be on the company's progress with its novel pipeline candidates targeting areas of high unmet medical need.

Zacks Equity Research

Zacks.com featured highlights include: Applied Therapeutics, Green Brick Partners, Frequency Therapeutics and Kelly Services

by Zacks Equity Research

Zacks.com featured highlights include: Applied Therapeutics, Green Brick Partners, Frequency Therapeutics and Kelly Services

Zacks Equity Research

LogicBio Therapeutics (LOGC) Catches Eye: Stock Jumps 7.1%

by Zacks Equity Research

LogicBio Therapeutics (LOGC) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Shrabana Mukherjee headshot

4 Stocks to Make the Most of New Analyst Coverage

by Shrabana Mukherjee

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Zacks Equity Research

Applied Therapeutics Inc. (APLT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Applied Therapeutics Inc. (APLT) closed the most recent trading day at $28.36, moving +0.32% from the previous trading session.

Zacks Equity Research

Moderna (MRNA) in Focus: Stock Moves 6.9% Higher

by Zacks Equity Research

Moderna (MRNA) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zacks Equity Research

Principia Biopharma (PRNB) Jumps: Stock Rises 6.8%

by Zacks Equity Research

Principia Biopharma (PRNB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zacks Equity Research

BeiGene (BGNE) in Focus: Stock Moves 8.7% Higher

by Zacks Equity Research

BeiGene (BGNE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Zacks Equity Research

Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (APLT) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Prothena (PRTA) Looks Good: Stock Adds 10.6% in Session

by Zacks Equity Research

Prothena (PRTA) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

Zacks Equity Research

89bio (ETNB) Jumps: Stock Rises 6.9%

by Zacks Equity Research

89bio (ETNB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zacks Equity Research

Pulmatrix (PULM) Catches Eye: Stock Jumps 6%

by Zacks Equity Research

Pulmatrix (PULM) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Zacks Equity Research

Corvus Pharmaceuticals (CRVS) Catches Eye: Stock Jumps 8.4%

by Zacks Equity Research

Corvus Pharmaceuticals (CRVS) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Zacks Equity Research

Seres Therapeutics (MCRB) in Focus: Stock Moves 10.8% Higher

by Zacks Equity Research

Seres Therapeutics (MCRB) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

Zacks Equity Research

Vaccinex (VCNX) Catches Eye: Stock Jumps 8.1%

by Zacks Equity Research

Vaccinex (VCNX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Zacks Equity Research

Magenta (MGTA) Looks Good: Stock Adds 5.2% in Session

by Zacks Equity Research

Magenta (MGTA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Zacks Equity Research

CRISPR Therapeutics (CRSP) Surges: Stock Moves 6.8% Higher

by Zacks Equity Research

CRISPR Therapeutics (CRSP) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zacks Equity Research

Zealand (ZEAL) Surges: Stock Moves 9.1% Higher

by Zacks Equity Research

Zealand (ZEAL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

Zacks Equity Research

Avid Bioservices (CDMO) Catches Eye: Stock Jumps 5.4%

by Zacks Equity Research

Avid Bioservices (CDMO) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Zacks Equity Research

Ascendis Submits BLA to FDA for TransConhGH in Pediatric GHD

by Zacks Equity Research

Ascendis Pharma (ASND) submits BLA to the FDA for TransConhGH for the treatment of pediatric growth hormone deficiency.

Zacks Equity Research

VBI Vaccines (VBIV) in Focus: Stock Moves 8.3% Higher

by Zacks Equity Research

VBI Vaccines (VBIV) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Zacks Equity Research

AquaBounty (AQB) Catches Eye: Stock Jumps 8.9%

by Zacks Equity Research

AquaBounty (AQB) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Zacks Equity Research

BeyondSpring (BYSI) Catches Eye: Stock Jumps 10.9%

by Zacks Equity Research

BeyondSpring (BYSI) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

Zacks Equity Research

Precigen (PGEN) Soars: Stock Adds 9.4% in Session

by Zacks Equity Research

Precigen (PGEN) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.